Quick Answer
Moderna, Inc. reported Operating Income of -$3.07 billion for fiscal year 2025.
Moderna, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$3.07B | +22.1% |
| 2024 | -$3.94B | +6.9% |
| 2023 | -$4.24B | -145.0% |
| 2022 | $9.42B | -29.2% |
| 2021 | $13.30B | +1842.6% |
| 2020 | -$763.00M | -39.7% |
| 2019 | -$546.00M | -32.1% |
| 2018 | -$413.27M | -53.4% |
| 2017 | -$269.36M | -20.4% |
| 2016 | -$223.77M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$260.00M | -271.4% | +71.3% |
| June 30, 2025 | -$907.00M | +33.5% | +13.6% |
| March 31, 2025 | -$1.05B | +17.1% | -1400.0% |
| September 30, 2024 | -$70.00M | +96.5% | +94.9% |
| June 30, 2024 | -$1.36B | +27.0% | -7.7% |
| March 31, 2024 | -$1.27B | -245.9% | +37.1% |
| September 30, 2023 | -$2.01B | -272.6% | -7.8% |
| June 30, 2023 | -$1.87B | -176.3% | -410.1% |
- Moderna, Inc. showed an increase of +22.1% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Moderna, Inc.’s operating income has declined by 1273.7% (from -$223.77 million to -$3.07 billion).
- The most recent figure is from Moderna, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: